Featured Posts

Friday, January 11, 2019

Thymoquinone holds a neuroprotective potential and could be a promising therapeutic agent to reduce the risk of developing Alzheimer's disease.

PMID:  Biochem Biophys Rep. 2019 Mar ;17:122-126. Epub 2019 Jan 3. PMID: 30623116 Abstract Title:  Neuroprotective efficacy of thymoquinone against amyloid beta-induced neurotoxicity in human induced pluripotent stem cell-derived cholinergic neurons. Abstract:  The natural antioxidant Thymoquinone (TQ) is the most abundant ingredient in the curative plant Nigella sativa seed's oil. An extensive number of studies have revealed that TQ is the most active and most responsible component for the plant's pharmacological properties. It has been documented in several studies that TQ has a wide range of protective activities and many neuropharmacological attributes. Amyloid beta (Aβ) is the major role player peptide in the progression of Alzheimer's disease (AD). Our current study has been implemented to explore the protective possibilities of TQ on Aβ-induced neurotoxicity. To test TQ's effect we used cultured human induced pluripotent stem cell (hiPSC)-derived cholinergic neurons. The obtained results showed that Aβcaused cell death and apoptosis, which was efficiently attenuated by the co-treatment of TQ. Moreover, TQ restored the decrease in the intracellular antioxidant enzyme glutathione levels and inhibited the generation of reactive oxygen species induced by Aβ. Furthermore, using the fluorescent dye FM1-43 we demonstrated that TQ was able to reduce synaptic toxicity caused by Aβ. Thus, the findings of our study suggest that TQ holds a neuroprotective potential and could be a promising therapeutic agent to reduce the risk of developing AD and other disorders of the central nervous system.

read more



from GreenMedInfo http://bit.ly/2FnTQ9i

No comments:

Post a Comment